Services
Related Practice Areas
Practice Contacts
Attorneys
Life Sciences Practice
Cantor Colburn clients work in a variety of life sciences disciplines including immunology, virology, molecular biology, animal and plant genetics, gene therapy, protein chemistry, pharmacology, enzymology, and bioinformatics. Our specific areas of patent expertise include synthetic and artificial antibodies; recombinant nucleic acids and proteins, including cytokines and antigenic proteins recombinant cytokines, recombinant antigens; vaccines, including recombinant viruses; antisense and inhibitory RNA technology; cloning; differential display technologies; genomics and genetic engineering; immunoassay methods; rational drug design; and synthesis and screening of combinatorial libraries. The Life Sciences Practice Group works closely with the Pharmaceutical Practice Group to provide an extensive array of intellectual property services and experience to clients working in all areas of the life sciences.
If enforcement of intellectual property rights and assets becomes necessary, Cantor Colburn’s Litigation Department is also adept in all aspects of IP law, including the life sciences. Our Hatch-Waxman litigation experience combined with our understanding of the biotechnology and pharmaceutical industries uniquely positions Cantor Colburn to assist clients in developing and implementing successful litigation strategies designed to achieve their business objectives.
Cantor Colburn clients work in a variety of life sciences disciplines including immunology, virology, molecular biology, animal and plant genetics, gene therapy, protein chemistry, pharmacology, enzymology, and bioinformatics. Our specific areas of patent expertise include artificial antibodies, recombinant cytokines, recombinant antigens, vaccines, antisense technology, cloning, differential display technologies, genomics and genetic engineering, immunoassay methods, rational drug design, and synthesis and screening of combinatorial libraries. Cantor Colburn’s Litigation Practice is also adept in all aspects of IP law, including the life sciences. Our Hatch-Waxman litigation experience combined with our understanding of the biotechnology and pharmaceutical industries uniquely positions Cantor Colburn to assist clients in developing and implementing successful litigation strategies designed to achieve their business objectives.
News
- September 30, 2024
- June 2023
- September 13, 2021
- December 1, 2020
- August 6, 2018
- July 16, 2018
Publications
- January 1, 2021
Events
- September 19, 2024
- June 3, 2024
- March 21, 2024
- March 5, 2024
- June 15, 2023
- June 5, 2023
- February 9, 2023
- May 17, 2022
- April 26, 2021
- December 6, 2019
- July 25, 2019
- June 3, 2019
- November 29, 2018
- October 24, 2018
- October 1, 2018
- September 12, 2018